The Trump administration says it is pulling half a billion dollars from U.S. government-funded research projects to create ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain's GSK and Germany's CureVac $740 million plus royalties to settle US legal disputes over Covid-19 vaccines, ...

The Department of Health and Human Services has cancelled contracts and pulled funding for 22 mRNA vaccine projects, totaling ...